Testing effectiveness (Phase 2)Study completedNCT04476017
What this trial is testing
Evaluate the Safety and Tolerability of SAGE-718 in Participants With Parkinson's Disease Mild Cognitive Impairment (PD-MCI)
Who this might be right for
Parkinson DiseaseCognitive Dysfunction
Supernus Pharmaceuticals, Inc. 18